DCF — ST. AGNES MEDICAL CENTER
Enterprise Value: $-1.3B
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-1.3B
Enterprise Value
$-416.1M
PV of Cash Flows
$-925.2M
PV of Terminal Value
$-1.5B
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $595.5M | $-88.0M | -15.0% | $-113.2M | $-102.9M |
| Year 2 | $613.4M | $-84.5M | -14.0% | $-110.5M | $-91.3M |
| Year 3 | $631.8M | $-80.8M | -13.0% | $-107.5M | $-80.8M |
| Year 4 | $650.8M | $-79.9M | -12.0% | $-107.5M | $-73.4M |
| Year 5 | $670.3M | $-80.6M | -12.0% | $-109.0M | $-67.7M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-1.3B. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$578.2M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.15282178615298875
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5